Background and purpose: Headache has been associated with various lifestyle and psychosocial factors, one of which is smoking. The aim of the present study was to investigate whether the association between smoking intensity and headache is likely to be causal. Method: A total of 58 316 participants from the Nord-Trøndelag Health (HUNT) study with information on headache status were genotyped for the rs1051730 C>T single-nucleotide polymorphism (SNP). The SNP was used as an instrument for smoking intensity in a Mendelian randomization analysis. The association between rs1051730 T alleles and headache was estimated by odds ratios with 95% confidence intervals. Additionally, the association between the SNP and migraine or non-migrainous headache versus no headache was investigated. All analyses were adjusted for age and sex. Results: There was no strong evidence that the rs1051730 T allele was associated with headache in ever smokers (odds ratio 0.99, 95% confidence interval 0.95-1.02). Similarly, there was no association between the rs1051730 T allele and migraine or non-migrainous headache versus no headache. Conclusion: The findings from this study do not support that there is a strong causal relationship between smoking intensity and any type of headache. Larger Mendelian randomization studies are required to examine whether higher smoking quantity can lead to a moderate increase in the risk of headache subtypes.
Introduction
Primary headache disorders are highly prevalent, with migraine and tension-type headache being the most common, affecting 14.7% and 20.8% of the world's population respectively [1] . As much as 15% of the population report absence from work during the last year because of headache, and migraine alone is ranked as the seventh leading cause of disability worldwide [2, 3] . Even though headache has been linked to various lifestyle and psychosocial factors [4] [5] [6] , there is limited actionable knowledge about modifiable risk factors. Headache patients are often advised to change their lifestyle, including stopping smoking and increasing their amount of physical exercise [5, 7] . However, the basis for such advice is largely based on epidemiological studies where definite conclusions about causal relationships cannot be drawn. Multiple studies have indicated that smoking is associated with headache with odds ratios from 1.3 to 1.5 [4, 5, 8] . The positive association seems to be true for both migraine and non-migrainous headache and is most evident amongst young adults [4] . Whether smoking causes headache or headache leads to altered smoking behavior is uncertain, however.
Mendelian randomization (MR) offers an alternative approach to conventional observational studies, with the potential for stronger causal claims [9] . In MR, genetic variants are used as proxies for the exposure of interest. Since genetic variants are transmitted from parents to offspring at random during meiosis, they are not generally susceptible to confounding and reverse causation bias [9] . The single-nucleotide polymorphism (SNP) rs1051730 is the strongest genetic variant related to smoking behavior identified in genome-wide studies to date [10, 11] . In smokers, each additional T allele of the rs1051730 SNP is associated with an increased intensity of smoking corresponding to around one additional cigarette per day [11, 12] . Our aim was to explore whether smoking intensity has a causal effect on headache, using an MR approach.
Materials and methods

Study population
All inhabitants aged 20 years or older living in the county of Nord-Trøndelag, Norway, were invited to participate in the Nord-Trøndelag Health (HUNT) study [13, 14] . For the present study, participants who had attended HUNT2 (1995) (1996) (1997) or HUNT3 (2006 HUNT3 ( -2008 were included ( Fig. 1 and Data S1). All participants in the HUNT study have signed a written informed consent regarding the use of data from questionnaires and blood samples for research purposes [13, 14] . The current study was approved by the Regional Committee for Medical and Health Research Ethics (REK), 2012/2291/REK South-East C.
Genotyping
The HUNT sample was genotyped using one of three different Illumina HumanCoreExome arrays (HumanCoreExome12 v1.0, HumanCoreExome12 v.1.1 and HumanCoreExome-24+ v1.1 with custom content). Imputation was performed using Minimac3 (v2.0.1, http://genome.sph.umich.edu/wiki/Minimac3) [15] with default settings and a customized Haplotype Reference Consortium release 1.1 (HRC v1.1) [16] (Data S1).
Smoking
Smoking status was self-reported and categorized as never, former and current daily smoker. Current smokers were asked to report the average number of cigarettes smoked per day (Data S1).
Outcome
In the HUNT questionnaire, those who answered 'yes' to 'Have you suffered from headache during the last 12 months?' were classified as headache sufferers. Those who answered 'no' were defined as headachefree controls. The headache sufferers were further classified as having migraine or non-migrainous headache, based on a modified version of the International Classification of Headache Disorders (ICHD II) [17] (Data S1).
Statistical methods
Descriptive statistics according to the number of rs1051730 T alleles were compared using the chisquared test for categorical variables and a linear regression for continuous variables. An additive genetic model was assumed, so risk estimates represent the odds ratios (ORs) per additional copy of the T allele.
Association between SNP and exposure Linear regression was used to estimate the association between rs1051730 T alleles and smoking intensity.
Association between exposure and outcome (observational analysis) Logistic regression with ORs and 95% confidence intervals (CIs) was used to estimate the relationship between smoking intensity, or smoking status, and headache (Data S1). In a sensitivity analysis, former smokers were restricted to those who reported smoking cessation >1 year ago to avoid bias from current smoking at the time of reporting headache.
Association between SNP and outcome (MR analysis)
Logistic regression was used to estimate the relationship between rs1051730 T alleles and headache (Data S1). The main analysis was in the strata of never versus ever smokers (current and former smokers combined). Additionally, the SNP-headache association was stratified by current, former or never smoking. In a secondary analysis, the association between the SNP and migraine or non-migrainous headache versus no headache was investigated using a multinomial logistic regression. The MR analysis was also performed stratified by age <40 vs. ≥40 [4] . All analyses were adjusted for age and sex. Additionally, body mass index (BMI) was adjusted for as a potential confounder/mediator.
Results
In total 58 316 participants were genotyped for rs1051730 and had information about headache. Of these, 25 666 (46.0%) were never smokers, 14 799 (26.5%) former smokers and 15 278 (27.4%) current smokers (Table 1) . Amongst the 58 316 participants, 39.4% reported headache, 12.9% had migraine and 26.5% had non-migrainous headache (Fig. 1) . The probability of being a current smoker and the number of cigarettes smoked per day increased by number of rs1051730 T alleles. There was a slight decrease in age and BMI according to increasing number of T alleles. There was no difference in the prevalence of headache according to the number of T alleles (Table 1) .
Association between SNP and exposure Amongst current smokers, each additional T allele was associated with 0.68, 95% CI 0.55-0.80, additional cigarettes smoked per day.
Observational analysis
There was a positive association between smoking intensity and headache (Fig. 2) . The association (OR) between each additional cigarette smoked per day and headache was 1.02 (95% CI 1.01-1.02). According to smoking status, both current smoking (OR 1.30, 95% CI 1.25-1.36) and former smoking (OR 1.24, 95% CI 1.19-1.30), compared to never smoking, were positively associated with headache. Former smokers (cessation >1 year ago) compared with never smokers also had increased odds of headache, OR 1.24 (95% CI 1.18-1.29).
Mendelian randomization analysis
There was no association between rs1051730 T alleles and headache in ever smokers (OR 0.99, 95% CI 0.95-1.02) or in never smokers (OR 1.00, 95% CI 0.96-1.04; Table 2 ). Moreover, there was no association between the rs1051730 T allele and headache in current smokers (OR 1.00, 95% CI 0.96-1.06; Table 3) .
No association was found between the T allele and migraine or non-migrainous headache versus no headache (Tables 2 and 3 ). Stratified analysis by age (<40 or ≥40 years) showed no statistically significant associations between the rs1051730 T allele and headache versus no headache (Table S1 ). Adjustments for BMI did not change the association between the T allele and any type of headache (data not shown).
Discussion
No evidence was found for a causal effect of smoking intensity on headache. Whilst a positive association was observed between the number of cigarettes smoked per day and headache, there was no association between the rs1051730 T alleles and any type of headache. The results indicate that there is no strong causal effect of smoking intensity on headache overall. The observational association between smoking status and headache in the present study is comparable to results from previous studies (ORs 1.3-1.6) [4, 5, 8] . Regarding smoking intensity, Gan et al. [18] found in a cross-sectional survey that the number of cigarettes smoked per day was associated with headache. Smoking between 11 and 18 cigarettes per day was associated with an OR of 1.53 for having headache, compared to never smokers [18] . In the observational analysis, the OR for headache was found to be 1.02 per cigarette, corresponding to an OR between 1.20 and 1.50 for headache if 10-20 cigarettes per day were smoked. The association between former smoking and headache was also present for former smokers who had quit smoking >1 year ago (OR 1.24), which confirmed that the observed association was not due to current smoking at the time of reporting headache alone. However, the magnitude of the observational effect estimate should not be given too much emphasis. The current study was designed for MR analysis, where the aim was to determine whether the association observed between smoking and headache is likely to be causal, and not for determining the exact magnitude of the effect estimate. The significant association found in the observational analysis, however, was not replicated in the MR analysis. Still, it cannot be refuted by our MR analysis that a moderate causal association of smoking intensity on headache exists, as the 95% CI for our MR analysis included the magnitude of the observational association.
A former study on the same HUNT population found an association between current smoking (for those who smoked ≥10 cigarettes per day) and headache, in those younger than 40 years of age (OR 1.50) but not in those aged ≥40 years [4] . However, the headache diagnoses in HUNT include only current headache (present within the last 12 months), which might partly explain this finding, since headache prevalence, and in particular migraine prevalence, is decreasing in older age groups [19] . Therefore stratifying by age 40 was carried out to investigate whether a causal effect of smoking might depend on age. Although the point estimate for the association was higher for those aged <40 years (OR 1.07) compared to those aged ≥40 (OR 0.97), there was no significant association in either group.
The large sample size and the use of a well-defined genetic instrument are strengths of this study. Using rs1051730 as a proxy for smoking intensity allowed Number of cigarettes per day Figure 2 Age-and sex-adjusted ORs for headache with 95% CI (grey) according to number of cigarettes smoked per day. Never and former smokers (zero cigarettes a day) are used as a reference group.
the relationship between smoking and headache to be examined in a pseudo-randomized manner, avoiding confounding and reversed causation. Another strength is the use of validated headache diagnoses, but the use of questionnaire-based diagnoses will necessarily give some degree of misclassification, which could deflate our estimates. This deflation would probably have been most pronounced for non-migrainous headache, which had the lowest agreement between questionnaire-based and interview diagnoses [20, 21] . Another limitation is that current headache only was assessed, causing headache sufferers who have become headache-free prior to baseline to be classified as controls. Such misclassification is likely to weaken any observed effect, in particular in the older age groups where cessation rates are high [19] . Non-participation in HUNT has been associated with an unhealthier lifestyle with respect to tobacco smoking, physical inactivity and poor somatic health status [22] . Non-responders to the headache question in the current study were more often men, current smokers and younger (data not shown). This is in line with the overall characteristics of non-responders to the headache questions in HUNT [23] . Whilst an effect of selection bias cannot be ruled out, it is unlikely that the association between rs1051730 and headache would be substantially different amongst participants versus non-participants.
Mendelian randomization studies rely on three main assumptions: (i) the genetic variant is associated with the exposure, (ii) the genetic variant is associated with the outcome through the studied exposure only and (iii) the genetic variant is independent of other factors that affect the outcome [9] . Regarding assumption (i), the association between rs1051730 and smoking intensity has been confirmed in previous genome-wide association studies [10, 11] and the association was verified in the current data. The second assumption is violated if the genetic variant has multiple effects or if the genetic variant is in linkage disequilibrium with another variant that affects the outcome in other ways than through the exposure of interest. If an association between the rs1051730 T allele and headache was found in never smokers this might be suspicious of such a violation since the SNP is a proxy for smoking intensity. This can be considered a test of the second assumption: that the genetic variant only operates on the outcome via its effect on the exposure (i.e. no pleiotropy) [9] . However, in our case, no association was seen in any of the strata of smoking status and the results did not change after adjustments for BMI.
Stratification of MR analysis by smoking status groups may lead to collider bias by conditioning on a common observed measure [9] , thus potentially introducing bias from confounders to the exposureoutcome association that may violate the third Headache versus no headache, adjusted for age and sex, n = 58 313 (all), n = 56 938 (according to never-ever smokers); b migraine or non-migrainous headache versus no headache, adjusted for age and sex, n = 58 313 (all), n = 56 938 (according to never-ever smokers). assumption. For this reason, the MR analysis was performed in broader strata of never versus ever smokers, and adjusted for BMI, but no association between the rs1051730 T alleles and headache was seen.
To conclude, this MR analysis suggests that there is no strong causal effect of smoking intensity on headache. However, larger MR studies are required to examine whether higher smoking quantity can lead to a moderate increase in the risk of headache subtypes.
